No abstract

The Mepivacaine drug is used as a local anesthetic in dentistry, which could exist as three different tautomers. Herein, geometry, energy behavior as well as tautomerization of these tautomers have been investigated by employing density functional theory (DFT) and considering the solvent effects with the polarizable continuum model (PCM) model. The most stable tautomer of the Mepivacaine has a carbonyl and an –NH amine groups in its structure. The frontier orbitals and the energy gap of the molecule have been computed using the natural bond orbital analysis (NBO). Also, the armchair (5,5) single wall carbon nanotube (SWCNT) was used for investigation of the noncovalent interactions of the Mepivacaine molecule with the pristine SWCNT and the –COOH functionalized SWCNT in several forms. Geometries of the possible forms have been optimized. The most stable form for noncovalent interactions of the drug with each of the pristine and functionalized SWCNTs have been determined. The intermolecular H-bonds have essential role in energy behavior of the noncovalent interactions between the Mepivacaine drug and the investigated SWCNTs.

The synthesis, optical properties, theoretical calculations, and antibacterial activities of a series of new red heterocyclic dyes derived from imidazo[1,2- a]pyridine are presented. 3-(Hydroxyimino)imidazo[1,2- a]pyridin-2(3 H)-ylidene)-1-arylethanones are obtained from the reaction of 3-nitroimidazo[1,2- a]pyridine with substituted acetophenone derivatives in good yields (65%–72%). The structures are confirmed by spectral and analytical data, and the optical properties of the dyes are characterized by spectrophotometry. Density functional theory calculations are performed to provide the optimized geometries and relevant frontier orbitals. Calculated electronic absorption spectra are also obtained by the time-dependent density functional theory method. Moreover, the antibacterial activities (minimum inhibitory concentration) of the new dyes against Gram-positive and Gram-negative bacterial species are determined (minimum inhibitory concentration: 5–200 μg mL−1).